This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Sionna Therapeutics found strong investor interest in its cystic fibrosis drugs,...
At a moment when medication therapy for sickle cell disease (SCD) leaves too man...
Pfizer’s Braftovi received accelerated FDA approval in December as a first-line ...
Fay’s $50 million Series B round was led by Goldman Sachs. In total, the company...
Teladoc Health’s acquisition of Catapult Health will add “another channel” to fu...
[Sponsored] In an interview, Redox CEO Trip Hofer shared why the company is well...
[Sponsored] Hidden costs can undermine your healthcare practice. A webinar spons...
What You Should Know: – Little Otter, a trailblazer in digital whole-family ment...
What You Should Know: – Paige, a provider of AI-powered pathology solutions, to...
What You Should Know: – Commure, a healthcare technology company, today announc...
What You Should Know: – myTomorrows, a global health technology company co...
Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing...
The following is a guest article by Muhammad Shujja, Digital Marketing Lead at A...
Plus, news about X4 Pharmaceuticals, Viracta Therapeutics, Crown Laboratories, Q...
It took one month for Johnson & Johnson to secure its $14 billion acquisition of...
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential ne...